Corpus Intelligence IC Memo — BRIDGEWAY HOSPITAL 2026-04-26 12:24 UTC
IC Memo — BRIDGEWAY HOSPITAL
Investment Committee Memorandum | AR | 127 beds | Grade D | EBITDA uplift $1.5M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

BRIDGEWAY HOSPITAL

CCN 044005 | PULASKI, AR | 127 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

BRIDGEWAY HOSPITAL is a 127-bed suburban community hospital in PULASKI, AR with $19.8M in net patient revenue and a 3.2% operating margin. The hospital serves a payer mix of 5.4% Medicare, 9.9% Medicaid, and 84.7% commercial.

Thesis: Undervalued. Our ML models identify $1.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 3.2% to 10.6% (+736bps).

Net Revenue HCRIS$19.8M
Current EBITDA COMPUTED$635K
Operating Margin COMPUTED3.2%
Occupancy HCRIS45.6%
Revenue / Bed COMPUTED$156K
Net-to-Gross HCRIS39.8%
Distress Probability ML52.4%

2. Market Context & Competitive Position

108
AR Hospitals
-7.6%
State Median Margin
33
Comparable Hospitals

AR has 108 Medicare-certified hospitals with a median operating margin of -7.6%. The target's margin of 3.2% places it above the state median. Among 33 size-comparable peers (64-254 beds), the median margin is 1.2%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (64-254), prioritizing same-state peers. 33 hospitals in the comp set.

HospitalStateBedsRevenueMargin
BRIDGEWAY HOSPITAL (Target)AR127$19.8M3.2%
MERCY MEDICAL CENTERAR236$366.7M7.7%
BAXTER REGIONAL MEDICAL CENTERAR169$282.2M-2.8%
BAPTIST HEALTH MEDICAL CENTER-AR200$278.0M0.2%
ST. VINCENT HOT SPRINGSAR220$258.6M6.6%
WHITE COUNTY MEDICAL CENTERAR179$251.3M3.4%
WHITE RIVER MEDICAL CENTERAR170$247.7M-11.9%
NEA BAPTIST MEMORIAL HOSPITALAR180$246.7M1.0%
CONWAY REGIONAL MEDICAL CENTERAR169$232.9M-14.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$417K+210bp18mo
Cost to Collect4.5%2.5%$397K+200bp12mo
Denial Rate Reduction12.0%6.5%$393K+198bp12mo
A/R Days Reduction5200.0%3800.0%$241K+122bp9mo
Clean Claim Rate88.0%96.0%$13K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$417K
Cost to Collect
$397K
Denial Rate Reduction
$393K
A/R Days Reduction
$241K
Clean Claim Rate
$13K
Total EBITDA Uplift$1.5M
Current EBITDA$635K
+ RCM Uplift+$1.5M
Pro Forma EBITDA$2.1M
Current Margin3.2%
Pro Forma Margin10.6%
WC Released (1x)$761K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$977K$18.8M19.24x80.7%
Base (11x exit)10.0x11.0x$977K$21.0M21.49x84.7%
Bull Case9.0x11.0x$879K$26.1M29.72x97.1%
Bull (12x exit)9.0x12.0x$879K$28.8M32.71x100.9%
Bear Case11.0x10.0x$1.1M$11.2M10.40x59.7%
Bear (11x exit)11.0x11.0x$1.1M$12.6M11.76x63.7%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighElevated distress probabilityModel estimates 52.4% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 33 hospitals with 64-254 beds
  • Same-state prioritization (n=34)
  • Comp margins: P25=-11.8% / P50=1.2% / P75=7.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.